NCT07513324 2026-04-07
Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0)
Dana-Farber Cancer Institute
Phase 2 Not yet recruiting
Clinical Trials
13 trialsNCT05483374 2026-04-03
EURACAN
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Recruiting
NCT07457099 2026-03-09
Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma
Zhujiang Hospital
Not yet recruiting
NCT06629038 2026-02-11
Estimating Jaw, Neck, and Shoulder Range of Motion Using an AI Model
National Taiwan University Hospital
Recruiting
NCT05894083 2026-02-02
A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)
University of Michigan Rogel Cancer Center
Phase 2 Recruiting
NCT05541016 2025-11-04
De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA
Mayo Clinic
Phase 2 Recruiting
NCT02882282 2025-10-23
Pembrolizumab in Treating Patients With High Risk Oral Intraepithelial Neoplasia
M.D. Anderson Cancer Center
Phase 2 Completed
NCT06728631 2025-02-24
Candonilimab and ATRA Acid for Prevention of Oral Cancer Recurrence in Patients With OPL
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2 Active not recruiting
NCT06091878 2024-08-09
INDAGA-UK
Royal Marsden NHS Foundation Trust
Not yet recruiting
NCT04489212 2024-02-08
Study of Mucosal Sparing Adjuvant Radiotherapy After Surgical Exploration in HPV+ Head and Neck Cancer of Unknown Primaries
Mayo Clinic
Phase NA Completed
NCT05192655 2024-02-07
KIVAL-KHT
Charite University, Berlin, Germany
Recruiting
NCT00537199 2016-05-13
OraTest in Combination With Visual Examination and Visual Examination Alone
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT00577902 2016-02-09
Nutritional Risk and Mucositis in Patients With Head and Neck Carcinoma Receiving Chemoradiation
University of Arkansas
Completed